Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3692250 | 0.80 | — | — | |
| SCHEMBL1157973 | 0.78 | HTT (0.39) | MEN1KMT2A | |
| SCHEMBL1157972 | 0.78 | HTT (0.39) | MEN1KMT2A | |
| SCHEMBL2406305 | 0.75 | — | — | |
| SCHEMBL28770883 | 0.75 | CA14 (0.55) | MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL27508616 | 0.72 | CA12 (0.33) | MEN1KMT2A | |
| SCHEMBL27501167 | 0.70 | ENPEP (0.39) | — | |
| SCHEMBL11499750 | 0.70 | — | — | |
| SCHEMBL11117381 | 0.70 | — | — | |
| SCHEMBL11038150 | 0.69 | MEN1 (0.32) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2010168351-A | METHOD FOR PRODUCING FLUORINE-CONTAINING ALKYLSULFONYLAMINOETHYL ALPHA-SUBSTITUTED ACRYLATES | CENTRAL GLASS CO LTD | 2010-08-05 | — | — | JP | disclosed |
| US-7115771-B2 | Process for producing fluorine-containing alkylsulfonylaminoethyl α-substituted acrylate | CENTRAL GLASS COMPANY, LIMITED (JP) | 2006-10-03 | — | — | US | disclosed |
| US-20050240052-A1 | Process for producing fluorine-containing alkylsulfonylaminoethyl a-substitued acrylate | CENTRAL GLASS COMPANY, LIMITED (JP) | 2005-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050240052-A1 | Process for producing fluorine-containing alkylsulfonylaminoethyl a-substitued acrylate | PFAS, AFF2, AFF1 | MEN1 754/4885KMT2A 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.